It’s no secret that air pollution is tied to lung disease and cancer, but a new study sheds light on the significant role of ...

New research from Northwestern Medicine shows that in some cases of severe COVID, the immune response actually killed cancer cells.Researchers are trying to harness that immune power into new cancer ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

Researchers found that the COVID-19 virus triggers immune changes that may one day be harnessed to help fight cancer.

"It's incredible, and a big surprise, that the same infection that caused so much devastation can help create a ...

Lung cancer is a devastating disease that affects many Northern New Yorkers. Dr. Francis Lee explains the main causes and how ...

November is Lung Cancer Awareness Month and Christ Hospital is hoping to get the word out about screenings and treatments.

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Immune cells produced during severe COVID-19 infection may shrink tumors. The unexpected mechanism offers a new therapeutic ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

Bristol Myers Squibb (BMY) has received a recommendation for approval from an expert panel of the European Medicines Agency ...